Means and methods for anti-vegf therapy

The present application relates to the field of cancer, particularly to colorectal cancer (CRC). A panel of biomarkers is presented hereinthat can be used to cluster CRC samples into distinct genetic subtypes. It further relates to the use of the clustering method on patients treated with an anti-VEGF therapy and the identification of anti-VEGF responsive genetic subtypes.

Patent Publication Number: EP3445869

Year filing: 2017

Year approval: 2020

Year publication: 2019

Status: Requested

Technology domains: Biotechnology

Validated for IOF-key: Yes

Attributed to: Associatie KULeuven